With a multibillion dollar investment from Microsoft and already 4 authorship credits on PubMed, ChatGPT is poised to disrupt Medical Affairs.
MAPS speaks with Tim Mikelhashvili and winners of his Medical Affairs Innovation Olympics about applications that can match patients with clinical trials and provide real-time input to provide context for clinical decisions.
In this episode, we look at the tools that exist to look deeper into data allowing MedInfo teams to truly contribute to the generation, analysis of Medical Insights.
2023 brings increased expectations from the FDA for patient-focused drug development (PFDD). Medical Affairs organizations need to develop new skills to put the patient voice at the center of drug, device, and diagnostic development and evaluation.
Medical Affairs professionals across the globe became first-time Innovation Olympians, responded to a bold challenge, celebrated competition, accelerated innovation together, and shared a memorable experience together.
MAPS speaks with Tim Mikhelashvili, CEO and Co-Founder of Amedea Pharma, and the winners of his Medical Affairs Olympics Competition, the CEOs of Discreedly and Inphronesis.
This series series of the Elevate Podcast illuminates the path scientific communication takes from teaching to diagnosis to treating all the way to changing, prolonging, and saving patient lives.
From space biology to patient voice to best practices for onboarding, here are highlights of the APPA/MAPS Joint Medical Affairs Summit in Sydney, Australia.
In today’s episode, hear from industry experts on how to design medical education programs successfully for today’s healthcare professionals.
In today’s episode, we’re talking with Joseph Zabinski, PhD, Senior Director, AI & Personalized Medicine at OM1 about Artificial Intelligence — specifically about how AI can accelerate diagnosis and treatment.